¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-24  
±³À°ÀÏÀÚ : 2018-11-24
±³À°Àå¼Ò : ¼­¿ïƯº°½Ã Àá½Ç ·Ôµ¥È£ÅÚ¿ùµå 3Ãþ Å©¸®½ºÅ»º¼·ë(¿Ü 1°³·ë)  
±³À°ÁÖÁ¦ : 2018 KALC International Conference
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ¹æÀ¯Áø
¿¬¶ôó : 02-6711-4767  
À̸ÞÀÏ : youjin@medrang.co.kr      
±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 300,000¿ø      
ºñ°í 30¸¸¿ø(Àü¹®ÀÇ, ±³¼ö) 25¸¸¿ø(Æç·Î¿ì, Àü°øÀÇ, °£È£»ç µî)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 Crystal 1 07:50~08:30 Optimal Treatment Sequence in EGFR Targeted Therapy with Long Term Perspective  Maximilian J. Hochmair(Otto Wagner Hospital, Vienna, Austria) 
±³À°½Ã°£ 11-24 Crystal 2 07:50~08:30 New Target Agent: Dabrafenib Plus Trametinib in Patients with BRAF Mutant Metastatic Non-Small Cell Lung Cancer  James Chung-man Ho(The University of Hong Kong, Hong Kong) 
±³À°½Ã°£ 11-24 Crystal 3 07:50~08:30 The Evolving Power of Immunotherapy : Tecentriq in Advanced Lung cancer  Takashi Seto(National kyushu cancer center, Japan) 
È޽Ġ11-24  08:30~09:00 Coffee Break  () 
±³À°½Ã°£ 11-24 Crystal 1,2,3 09:00~09:30 Basic Perspective for Immunotherapy in Lung Cancer  Eui Cheol Shin(KAIST, Korea) 
±³À°½Ã°£ 11-24 Crystal 1,2,3 09:30~10:00 Clinical Perspective for Current Immunotherapy in NSCLC  Michael Boyer(Chris O¡¯Brien Lifehouse, Australia) 
±³À°½Ã°£ 11-24 Crystal 1,2,3 10:00~10:30 Beyond PD-l/PD-L1 Inhibitor: New Targeted Immunotherapy or Combination Therapy  Tien Hoang(Genentech, USA) 
È޽Ġ11-24  10:30~11:00 Coffee Break  () 
±³À°½Ã°£ 11-24 Crystal 1,2 11:00~11:30 The Value Proposition of Liquid Biopsies to Precision Medicine  Richie Soong(Yong Loo Lin School of Medicine, Singapore) 
±³À°½Ã°£ 11-24 Crystal 3 11:00~11:30 The Clinical Correlation of the 8th AJCC Staging System in Lung Adenocarcinoma Focusing on Early Stage Patients: Taiwan Experience  Shiu-Feng Huang(Institute of Molecular and Genomic Medicine, Taiwan) 
±³À°½Ã°£ 11-24 Emerald 11:00~11:30 Korean Lung Cancer Screening Project: Initial Results  Hyae Young Kim(National Cancer Center, Korea) 
±³À°½Ã°£ 11-24 Crystal 1,2 11:30~12:00 Liquid Biopsy Successfully Detects Best Drugs for Treating Lung Cancer  James Yang(National Taiwan University Hospital, Taiwan) 
±³À°½Ã°£ 11-24 Crystal 3 11:30~12:00 Lung Cancers with Multiple Pulmonary Sites of Involvement in the Eighth Edition of the TNM Classification  Hyo Sup Shim(Yonsei Univ., Korea) 
±³À°½Ã°£ 11-24 Emerald 11:30~12:00 Lung Cancer Screening: European Experience  Matthijs Oudkerk(NELSON, Netherlands) 
±³À°½Ã°£ 11-24 Crystal 1,2 12:00~12:30 Extracellular Vesicles(EV)-derived DNA for Liquid Biopsy in Lung Cancer  Kye Young Lee(Konkuk Univ., Korea) 
±³À°½Ã°£ 11-24 Crystal 3 12:00~12:30 Clinical Significance of New WHO Classification of Lung Cancer  Hironori Ninomiya(The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Japan) 
Åä·Ð 11-24 Emerald 12:00~12:30 Question and Answer  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó¾ÏÇÐȸ 2018 KALC International Conference : 2018-11-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø 2018 ´ëÇÑÇǺθ鿪ÇÐȸ ½ÉÆ÷Áö¿ò : 2018-11-24
´ÙÀ½±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ 2018³â MURUP HOSPITAL LIVE SURGERY : 2018-11-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21107 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 ºñ´¢»ý½Ä¿µ»óÀÇÇÐ ¿¬¼ö°­Á : 2024-07-07 0 111 2024-06-19
21106 ¼­¿ï 2024³â Çϰ迬¼ö°­Á ¹× Á¦1ȸ ¿¹¹æÁ¢Á¾ ½ÉÆ÷Áö¾ö : 2024-07-07 0 50 2024-06-19
21105 ¼­¿ï Á¦34Â÷ ÀÏÂ÷ÀÇ·áÀÎÀ» À§ÇÑ ³»½Ã°æ ¿¬¼ö°­Á : 2024-07-07 0 63 2024-06-19
21104 ºÎ»ê Á¦6±â ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤ : 2024-07-07 0 119 2024-06-19
21103 ´ë±¸ ´ë±¸°æºÏ³»°úÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-07 0 114 2024-06-19
21102 ¼­¿ï Á¦17ȸ ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³âÁúȯ ½ÉÆ÷Áö¾ö : 2024-07-07 0 107 2024-06-19
21101 ¼­¿ï Á¦13ȸ ÁßÀå³â ¿©¼º°Ç°­ ¿¬¼ö°­Á : 2024-06-30 0 63 2024-06-18
21100 ¼­¿ï ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ Á¦21Â÷ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-30 0 21 2024-06-18
21099 ¼­¿ï Á¦ 3ȸ ´ëÇѼҾÆû¼Ò³âÇൿ¹ß´ÞÁõÁø Çмú´ëȸ : 2024-06-30 0 85 2024-06-18
21098 ¼­¿ï 2024 ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-07 0 57 2024-06-19
21097 ´ëÀü Á¦ 19Â÷ ´ëÀüÃæûÁöȸ Åõ¼®½ÉÆ÷Áö¾ö : 2024-07-07 0 45 2024-06-19
21096 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Á¦22ȸ ¿À°ø ½ÉÆ÷Áö¾ö : 2024-07-07 0 103 2024-06-19
21095 ºÎ»ê Á¦ 9Â÷ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2024-07-07 0 58 2024-06-19
21094 ¼­¿ï Á¦ 2ȸ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-07 0 45 2024-06-19
21093 ºÎ»ê (ÇÏÀ̺긮µå) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦2ȸ ¿¬¼ö°­Á : 2024-07-07 0 57 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷